AIM
EBS icon

Assured Investment Management’s Emergent Biosolutions EBS Stock Holding History

Assured Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,008
Closed -$51K – 268
2019
Q1 		$51K Sell
1,008
-8,261
-89% -$487K ﹤0.01% 961
2018
Q4 		$549K Buy
9,269
+4,559
+97% +$294K 0.02% 625
2018
Q3 		$310K Sell
4,710
-2,017
-30% -$118K 0.01% 887
2018
Q2 		$340K Sell
6,727
-9,494
-59% -$495K 0.01% 919
2018
Q1 		$854K Buy
+16,221
New +$808K 0.02% 600

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Assured Investment Management's EBS Position: Q2 2019 in Review

Assured Investment Management sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 1,008 shares — an estimated $51K sold.

Assured Investment Management first reported a position in EBS in Q1 2018 and held it in 5 quarters. The position peaked at $854K in Q1 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Assured Investment Management reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,008 Emergent Biosolutions shares in Q2 2019, an estimated $51K.
  • Assured Investment Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Emergent Biosolutions position peaked at $854K in Q1 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.